The importance of spirometry in COPD and asthma: effect on approach to management.

COPD is characterized by airflow limitation. The diagnosis is suggested by history and physical examination and is confirmed by spirometry (ie, a low FEV(1) level that is unresponsive to bronchodilators). Once diagnosed, there is no widely accepted staging or severity scoring system. COPD presently is graded using a single measurement such as FEV(1), which, unlike the case with asthma, has a limited role in disease management. A more comprehensive staging system is required incorporating, for example, age, arterial blood gases, dyspnea, body mass index, and distance walked, in addition to FEV(1). These criteria should allow for more evidence-based recommendations for management of this condition. Asthma is an inflammatory disease also characterized by airflow limitation. But in contrast with COPD, the airflow limitation is highly reversible either spontaneously or with therapy. Repeated lung function measurements using portable peak flowmeters have resulted in improved outcomes. Therefore, frequent flow determination is recommended in the routine management of asthma. Treatment with anti-inflammatory agents and close monitoring of lung function should help decrease the morbidity and mortality associated with asthma.

[1]  G. Patterson,et al.  Results of 150 consecutive bilateral lung volume reduction procedures in patients with severe emphysema. , 1996, The Journal of thoracic and cardiovascular surgery.

[2]  P. Dekhuijzen,et al.  Disease monitoring in chronic obstructive pulmonary disease: is there a role for biomarkers? , 1997, The European respiratory journal.

[3]  R. Zuwallack,et al.  Variables related to increased mortality following out-patient pulmonary rehabilitation. , 1996, The European respiratory journal.

[4]  Third Expert Panel on theDiagnosis,et al.  Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma , 1997 .

[5]  W. Bailey,et al.  Effects of Smoking Intervention and the Use of an Inhaled Anticholinergic Bronchodilator on the Rate of Decline of FEV1 , 1994 .

[6]  J M Ignacio-Garcia,et al.  Asthma self-management education program by home monitoring of peak expiratory flow. , 1995, American journal of respiratory and critical care medicine.

[7]  B. Fleury,et al.  Work of breathing in patients with chronic obstructive pulmonary disease in acute respiratory failure. , 2015, The American review of respiratory disease.

[8]  W. Thurlbeck,et al.  Alveolar attachments in emphysema of human lungs. , 1991, The American review of respiratory disease.

[9]  J. Virchow,et al.  Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage. , 1992, The American review of respiratory disease.

[10]  B. B. Ross,et al.  A comparison of conventional spirometric tests and the test of closing volume in an emphysema screening center. , 1973, The American review of respiratory disease.

[11]  F. Martinez,et al.  Factors influencing ventilatory muscle recruitment in patients with chronic airflow obstruction. , 1990, The American review of respiratory disease.

[12]  Y Kikuchi,et al.  Chemosensitivity and perception of dyspnea in patients with a history of near-fatal asthma. , 1994, The New England journal of medicine.

[13]  R. Peto,et al.  The natural history of chronic airflow obstruction. , 1977, British medical journal.

[14]  W. Roche.  Fibroblasts and asthma , 1991, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[15]  N. Anthonisen.  Prognosis in chronic obstructive pulmonary disease: results from multicenter clinical trials. , 1989, The American review of respiratory disease.

[16]  J. Wain,et al.  Preoperative predictors of operative morbidity and mortality in COPD patients undergoing bilateral lung volume reduction surgery. , 1997, Chest.

[17]  A. Grassino,et al.  Inspiratory muscle dysfunction and chronic hypercapnia in chronic obstructive pulmonary disease. , 1991, The American review of respiratory disease.

[18]  Anthonisen Nr,et al.  Bronchodilator response in chronic obstructive pulmonary disease. , 1986 .

[19]  N. Jones,et al.  Respiratory muscles and dyspnea. , 1988, Clinics in chest medicine.

[20]  L. Fabbri,et al.  Mechanisms of occupational asthma , 1994, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[21]  E. Wouters,et al.  Weight Loss Is a Reversible Factor in the Prognosis of Chronic Obstructive Pulmonary Disease , 1998 .

[22]  B. Make,et al.  Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society. , 1995, American journal of respiratory and critical care medicine.

[23]  P. Macklem,et al.  Significance of the relationship between lung recoil and maximum expiratory flow. , 1967, Journal of applied physiology.

[24]  H. Gautier,et al.  Hypoxemia, hypercapnia, and breathing pattern in patients with chronic obstructive pulmonary disease. , 2015, The American review of respiratory disease.

[25]  S T Holgate,et al.  Exposure to house-dust mite allergen (Der p I) and the development of asthma in childhood. A prospective study. , 1990, The New England journal of medicine.

[26]  W. Busse,et al.  Inflammation and asthma. , 1995, Clinics in chest medicine.

[27]  R. Ebert.  Elasticity of the lung in pulmonary emphysema. , 1968, Annals of internal medicine.

[28]  A. Grassino,et al.  Force reserve of the diaphragm in patients with chronic obstructive pulmonary disease. , 1983, Journal of applied physiology: respiratory, environmental and exercise physiology.

[29]  N. Anthonisen,et al.  Prognosis in chronic obstructive pulmonary disease. , 1990, The American review of respiratory disease.

[30]  P. Barnes,et al.  Inhaled glucocorticoids for asthma. , 1995, The New England journal of medicine.

[31]  R. Stanford,et al.  The morphologic features of the bronchi, bronchioles, and alveoli in chronic airway obstruction: a clinicopathologic study. , 1976, The American review of respiratory disease.